Adam

ECB supports macroprudential policy actions taken in response to coronavirus outbreak

ECB supports the swift action taken by euro area macroprudential authorities to address the financial sector impact of the coronavirus outbreak by releasing or reducing capital buffers Macroprudential measures will free up more than €20 billion of bank capital to absorb losses and support lending Measures complement and reinforce microprudential measures taken by ECB The […]

Global regulators stress need for robust evidence on COVID-19 treatments

International regulators have published a report [link] today highlighting their considerations on the development of potential COVID-19 therapeutics, clinical trials and compassionate use programmes. The report presents the outcomes of a workshop on COVID-19 therapeutic medicine development that was organised by EMA under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA).